2000 Honda Accord Ex Sedan Silver on 2040-cars

Auto blog

Is Fernando Alonso preparing to sit out 2016?

Things have not been going well for Fernando Alonso since moving to McLaren. In fact they've been going so poorly that the Spanish driver may end up sitting out next season if things don't improve. At least those are the rumors presently occupying the Formula One paddock. The notion was first raised by McLaren chief Ron Dennis. When asked by reporters about Alonso's near-term future with the team, Dennis said, "I have an open mind to anything, and some of the ideas have involved those sorts of considerations, yes, sabbatical years etcetera." Though far from confirmed, the basic idea would be to see how next year's car performs in pre-season testing, and if it's not up to spec, Alonso could end up sitting out a season while McLaren and Honda get their partnership up to speed, so to speak. Alonso appeared to be puzzled by the prospect his boss raised, but couldn't rule it out, either. It would be a rather unprecedented move, but could end up avoiding some frustrations as the Anglo-Japanese teething process works itself out with time. Alonso has been a constant on the grid since 2003, missing only two grands prix in thirteen seasons: the 2005 United States Grand Prix at Indianapolis when all the Michelin-equipped teams sat out the race in protest, and the Australian Grand Prix at the beginning of this year, when Alonso was still recovering from a crash in pre-season testing. Out of 254 grands prix contested to date, Fernando has landed on the podium 97 times, including 32 wins and two world championships. This season, however, he's only finished in the points once, with his fifth-place finish in Hungary. Of the eighteen races he contested this year, his car failed to get him to the finish line altogether at seven. His seventeenth place in the final standings for the season are the worst he's done since his debut in 2001 with Minardi (the team now known as Toro Rosso). News Source: Autosport (1), (2), (3)Image Credit: Clive Mason/Getty Hirings/Firings/Layoffs Motorsports Honda McLaren F1 mclaren-honda

Mazda3 sales off to rocky start despite massive critical acclaim

Like just about every other auto publication we've seen, we loved the way the Mazda3 drove when we reviewed it a few months ago, but those glowing reviews apparently aren't helping its sales. The new compact may be falling victim to a sales war between the Toyota Corolla and Honda Civic, with the newcomer getting squeezed out by those with more established names and bigger marketing budgets.
According to Automotive News, Mazda3 sales have fallen every month since last August, and its sales are down 27 percent in the first two months of 2014. It certainly isn't helping that the entire compact segment is down five percent this year as well.
The biggest problem for the new model seems to be its price compared to rivals. Mazda is not offering the incentives that are on the hood of competitors. With the previous generation, the company offered more than $2,700 on the hood to move them out, but the current model only carries about $1,233 in markdowns, according to AN.

Honda Walking Assist Device begins US testing at Rehabilitation Institute of Chicago

For years, we've been wondering what implications Honda's Asimo robot could have in the real world, and now we're starting to get a sense of that. Honda announced that it will begin its first US clinical studies of the Walking Assist Device at the Rehabilitation Institute of Chicago in an effort to provided improved mobility for people who have suffered a stroke. While the automotive tie-in here is pretty weak, this is the first time we've heard about this device since it was unveiled back in 2008.
Weighing in at six pounds, Honda's device is fitted to the waist and legs of patients to make it easier to walk, and the 22.2-volt lithium-ion battery provides enough electricity for more than an hour of operation. According to Honda's press release, which is posted below, up to 80 percent of the almost 800,000 stroke victims each year (in the US alone) are afflicted with limited mobility, so a medical aid like this could have a big impact in the real world.